Dry Eye Syndrome Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2016 – 2025

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Dry Eye Syndrome Market Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Dry Eye Syndrome Market by Type: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Evaporative Dry Eye

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Aqueous Dry Eye

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Dry Eye Syndrome Market: by Treatment: Market Size and Forecast, 2019 – 2028

5.1  Overview

5.2  Nutritional Supplements

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.3  Serum Eye Drop

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.4  Lubricant Eye Drop

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.5  Lubricant Eye Drop(Oily Tear Eye Drops)

5.5.1   Current Trend and Analysis

5.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.6  Lubricant Eye Drop(Ointments)

5.6.1   Current Trend and Analysis

5.6.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.6.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.7  Lubricant Eye Drop(Preservative – Free Drops)

5.7.1   Current Trend and Analysis

5.7.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.7.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.8  Anti-Inflammatory Drugs

5.8.1   Current Trend and Analysis

5.8.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.8.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.9  Anti-Inflammatory Drugs (Tetracyclines)

5.9.1   Current Trend and Analysis

5.9.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.9.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.10 Anti-Inflammatory Drugs(Corticosteroids)

5.10.1 Current Trend and Analysis

5.10.2 Market Size and Forecast, 2019 - 2028 ($ Billion)

5.10.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 6        Global Dry Eye Syndrome Market by Geography: Market Size and Forecast, 2019 - 2028

6.1  Overview

6.1.1   Global Dry Eye Syndrome Market Year-on-Year Growth, by region 2020 – 2028 (%)

6.2  North America

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3   U.S.

6.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3.2        By Type

6.2.3.3        By Treatment

6.2.4   Canada

6.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.4.2        By Type

6.2.4.3        By Treatment

6.2.5   Mexico

6.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.5.2        By Type

6.2.5.3        By Treatment

6.3    Europe

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3   Germany

6.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3.2        By Type

6.3.3.3        By Treatment

6.3.4   France

6.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.4.2        By Type

6.3.4.3        By Treatment

6.3.5   U.K

6.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.5.2        By Type

6.3.5.3        By Treatment

6.3.6   Spain

6.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.6.2        By Type

6.3.6.3        By Treatment

6.3.7   Others

6.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.7.2        By Type

6.3.7.3        By Treatment

6.4    Asia-Pacific

6.4.1   Current Trend and Analysis

6.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3   India

6.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3.2        By Type

6.4.3.3        By Treatment

6.4.4   China

6.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.4.2        By Type

6.4.4.3        By Treatment

6.4.5   Japan

6.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.5.2        By Type

6.4.5.3        By Treatment

6.5    RoW

6.5.1   Current Trend and Analysis

6.5.2   Market Size and Forecast

6.5.3   South America

6.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.3.2        By Type

6.5.3.3        By Treatment

6.5.4   Middle East

6.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.4.2        By Type

6.5.4.3        By Treatment

6.5.5   Africa

6.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.5.2        By Type

6.5.5.3        By Treatment

Chapter 8        Company Profiles

7.1  Santen Pharmaceutical

7.1.1     Company Overview

7.1.2     Product Portfolio

7.1.3     Business Strategies

7.1.4     Financials

7.1.5     Recent Developments

7.2  Alcon

7.2.1     Company Overview

7.2.2     Product Portfolio

7.2.3     Business Strategies

7.2.4     Financials

7.2.5     Recent Developments

7.3  Shire

7.3.1     Company Overview

7.3.2     Product Portfolio

7.3.3     Business Strategies

7.3.4     Financials

7.3.5     Recent Developments

7.4  Allergan

7.4.1     Company Overview

7.4.2     Product Portfolio

7.4.3     Business Strategies

7.4.4     Financials

7.4.5     Recent Developments

7.5  Eyegate Pharma

7.5.1     Company Overview

7.5.2     Product Portfolio

7.5.3     Business Strategies

7.5.4     Financials

7.5.5     Recent Developments